Gapping up
In reaction to strong earnings/guidance: IDI +16.2%, HOTR +11.5%, EROS +10.8%, NUAN +9.4%, CMCM +7.2%, SOL +4.5%, TGLS +4.1%, MBT +4%, JASO +3.3%, MY +2.8%, HD +2.8%, WMT +2.2%, RLGT +1.1%
M&A news: IDI +16.2% (will acquire Fluent for $100 mln in cash and 15 mln shares in stock), BUD +1.8% (cont volatility surrounding merger with SABMiller), P +1.2% (confirms agreement to acquire several key assets from Rdio for $75 mln)
Select large pharma related names showing strength: GSK +1.2%, SNY +1.1%, AZN +0.9%, NVO +0.6%
Other news: OCRX +18% (Announces Positive Phase 1 Results for Oral OCR-002 in Development for the Prevention of Chronic Hepatic Encephalopathy), VIPS +4.8% (cont strength), JKS +3.6% (in sympathy with solar peers reporting today), GOV +2.6% (announced the declaration of a pro rata distribution of approximately half of the shares of Class A Common Stock of The RMR Group Inc), HERO +2% (Soros Fund Management discloses 7.02% passive stake in 13G filing), JD +1.9% (cont strength), GE +1.6% (says offer to exchange shares of GE common stock for shares of Synchrony Financial (SYF) was 3.2x oversubscribed; Completion reduces ENI by $65 bln), SAVE +1.6% (favorable commentary on Monday's Mad Money), OHI +0.9% (filed for offering of common stock for selling stockholders), XCO+0.9% (shareholders approved amendment to effect reverse split; Board has deferred decision after regaining NYSE compliance for continued listing standards), JCP +0.8% (expanded revolving line of credit; plans to retire outstanding principal amount of its $500 mln Term Loan)
Analyst comments: PRAA +3.8% ( upgraded to Strong Buy from Mkt Perform at Raymond James), SHPG +1.0% (upgraded to Outperform from Mkt Perform at Leerink Partners)
In reaction to strong earnings/guidance: IDI +16.2%, HOTR +11.5%, EROS +10.8%, NUAN +9.4%, CMCM +7.2%, SOL +4.5%, TGLS +4.1%, MBT +4%, JASO +3.3%, MY +2.8%, HD +2.8%, WMT +2.2%, RLGT +1.1%
M&A news: IDI +16.2% (will acquire Fluent for $100 mln in cash and 15 mln shares in stock), BUD +1.8% (cont volatility surrounding merger with SABMiller), P +1.2% (confirms agreement to acquire several key assets from Rdio for $75 mln)
Select large pharma related names showing strength: GSK +1.2%, SNY +1.1%, AZN +0.9%, NVO +0.6%
Other news: OCRX +18% (Announces Positive Phase 1 Results for Oral OCR-002 in Development for the Prevention of Chronic Hepatic Encephalopathy), VIPS +4.8% (cont strength), JKS +3.6% (in sympathy with solar peers reporting today), GOV +2.6% (announced the declaration of a pro rata distribution of approximately half of the shares of Class A Common Stock of The RMR Group Inc), HERO +2% (Soros Fund Management discloses 7.02% passive stake in 13G filing), JD +1.9% (cont strength), GE +1.6% (says offer to exchange shares of GE common stock for shares of Synchrony Financial (SYF) was 3.2x oversubscribed; Completion reduces ENI by $65 bln), SAVE +1.6% (favorable commentary on Monday's Mad Money), OHI +0.9% (filed for offering of common stock for selling stockholders), XCO+0.9% (shareholders approved amendment to effect reverse split; Board has deferred decision after regaining NYSE compliance for continued listing standards), JCP +0.8% (expanded revolving line of credit; plans to retire outstanding principal amount of its $500 mln Term Loan)
Analyst comments: PRAA +3.8% ( upgraded to Strong Buy from Mkt Perform at Raymond James), SHPG +1.0% (upgraded to Outperform from Mkt Perform at Leerink Partners)